The Motley Fool

3 dividend investment trusts I’d buy to fund my retirement

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Image: Public domain

Investment trusts can be a great way to add diversification to your portfolio. With one simple trade, you have the ability to invest in a portfolio of securities, managed by a professional fund manager. With that in mind, today I’m looking at three dividend-focused investment trusts that could appeal to those looking for high levels of income from their portfolios. 

Murray Income Trust

Run by Aberdeen Asset Management, the Murray Income Trust (LSE: MUT) is an investment trust that aims to achieve a high and growing income, combined with capital growth. The trust invests predominantly in UK equities, however it does have the freedom to diversify into international stocks. 

5G is here – and shares of this ‘sleeping giant’ could be a great way for you to potentially profit!

According to one leading industry firm, the 5G boom could create a global industry worth US$12.3 TRILLION out of thin air…

And if you click here we’ll show you something that could be key to unlocking 5G’s full potential...

At the end of June, the top holdings in the trust included Unilever (4.5%), British American Tobacco (4.5%) and GlaxoSmithKline (4.5%), and the largest international positions were Roche (3.4%), Nordea Bank (3.1%) and Microsoft (2.5%). Sector-wise, the trust had the largest exposure to the financials, consumer goods and healthcare sectors. 

Dividends are paid quarterly, and the total dividend paid last year was 32.25p last year, equating to a yield of a healthy 4% at the current share price. The trust has an excellent dividend growth track record, having raised its payout 43 years in a row. Ongoing charges are 0.76%. 

Temple Bar Investment Trust

With 33 years of consecutive dividend growth, the Temple Bar Investment Trust (LSE: TMPL) is another trust that could appeal to dividend investors. 

Launched in 1926, it aims to provide growth in income and capital, and to outperform the FTSE All-Share Index on a total return basis. The trust invests primarily in UK securities, with the majority of portfolio holdings selected from the FTSE 350 index. The portfolio manager uses a contrarian approach to value investing, seeking out undervalued, out-of-favour companies with strong balance sheets. 

At the end of June, the three largest sectors in the trust were financials, cash & short-dated gilts and industrials. The top three holdings were HSBC Holdings (8.1%), GlaxoSmithKline (6.8%) and Grafton Group (5.2%).

Dividends are paid quarterly, and last year it paid out a total of 40.45p, equating to a yield of 3.1% at present. Ongoing charges are 0.51%. 

Merchants Trust 

Lastly, the Merchants Trust (LSE: MRCH) is another trust that has a strong focus on dividend-paying companies. Its objective is to provide an above-average level of income, income growth and long-term capital growth by mainly investing in higher-yielding FTSE 100 stocks. 

Established in 1889, the trust is managed by Allianz Global Investors, with the portfolio manager often looking to go against the herd and invest in high-quality stocks that are out of favour. At the end of June, the trust had the largest exposure to the financials, industrials and consumer services sectors, and the three largest holdings were GlaxoSmithKline (7.4%), Royal Dutch Shell (7.2%) and HSBC Holdings (5.9%).

The Merchants Trust has the highest yield of the three, with this year’s dividend payment of 24.2p equalling a yield of an impressive 5%. Dividends have been increased for 35 consecutive years and are paid on a quarterly basis. Ongoing charges are 0.58%. 

“This Stock Could Be Like Buying Amazon in 1997”

I'm sure you'll agree that's quite the statement from Motley Fool Co-Founder Tom Gardner.

But since our US analyst team first recommended shares in this unique tech stock back in 2016, the value has soared.

What's more, we firmly believe there's still plenty of upside in its future. In fact, even throughout the current coronavirus crisis, its performance has been beating Wall St expectations.

And right now, we're giving you a chance to discover exactly what has got our analysts all fired up about this niche industry phenomenon, in our FREE special report, A Top US Share From The Motley Fool.

Click here to claim your copy now — and we’ll tell you the name of this Top US Share… free of charge!

Edward Sheldon owns shares in GlaxoSmithKline and Royal Dutch Shell. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline and Unilever. The Motley Fool UK has recommended HSBC Holdings and Royal Dutch Shell B. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

Our 6 'Best Buys Now' Shares

Renowned stock-picker Mark Rogers and his analyst team at The Motley Fool UK have named 6 shares that they believe UK investors should consider buying NOW.

So if you’re looking for more stock ideas to try and best position your portfolio today, then it might be a good day for you. Because we're offering a full 33% off your first year of membership to our flagship share-tipping service, backed by our 'no quibbles' 30-day subscription fee refund guarantee.

Simply click below to discover how you can take advantage of this.